Filing metadata

Accession number
0000950170-24-136023
Form type
Form 4
Filer
Akero Therapeutics, Inc.
CIK
CIK 1744659
Filed
Dec 12, 2024
Reporting period
Dec 10, 2024
Description
Insider transaction

Explore SEC Filings Hub